ClinicalTrials.gg
Not yet recruitingNCT07911254Updated Nov 2, 2026

Comparative Effects of Dynamic Cupping and Facilitated Positional Release in Cervicogenic Headache

An interventional study of Dynamic Cupping and Facilitated Positional Release technique in Cervicogenic Headache, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

Cervicogenic headache (CGH) is a secondary headache disorder originating from structural and functional impairments of the cervical spine, accounting for approximately 15-20% of all chronic headaches worldwide. It is characterized by unilateral head pain referred from the osseous, discal, or soft tissue elements of the upper cervical spine, frequently accompanied by restricted cervical range of motion, myofascial tenderness, significant neck disability, and disrupted sleep quality. Due to prolonged poor posture, repetitive neck movements, and increased sedentary lifestyles, the prevalence of cervicogenic headache has increased significantly in recent years. Although various physiotherapy interventions are available for its management, identifying the most effective conservative treatment approach remains a challenge due to the multifactorial nature and complexity of the condition, highlighting the need for further research. This study therefore aims to conduct the first randomized clinical trial directly comparing the effects of Dynamic Cupping and Facilitated Positional Release across five clinically relevant, multidimensional outcomes in patients with cervicogenic headache specifically pain intensity, headache impact, cervical range of motion, neck disability, and sleep quality.

The study design will be a randomized clinical trial. Non-probability Consecutive sampling technique will be used, and participants will be randomly allocated into two groups. Evaluation will be done using the Numeric Pain Rating Scale (NPRS), Headache Impact Test (HIT-6), Universal Goniometer (UG), Neck Disability Index (NDI), and Pittsburgh Sleep Quality Index (PSQI). Group A will receive Dynamic Cupping therapy, while Group B will receive Facilitated Positional Release technique. Both groups will receive three treatment sessions per week over four weeks, totaling 12 sessions, alongside a standardized baseline conventional therapy comprising hot pack application and cervical muscle stretches and Isometrics. Measurements of all outcome variables will be taken at baseline and after 4 weeks. The collected data will be analyzed using SPSS version 25.

02

Conditions studied

  • Cervicogenic Headache

Keywords

  • Dynamic cupping
  • Facilitated Positional Release
  • Cervical range of motion
  • Pain intensity
  • Headache impact
  • Neck Disability Index
  • Sleep quality
03

In context

Post-Traumatic Headache

197 studies on the registry are indexed under Post-Traumatic Headache; 53 are open to participants now.

This study's planned enrollment of 41 is close to the median of 44 across 173 interventional studies indexed under Post-Traumatic Headache.

Browse Post-Traumatic Headache studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 34 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants aged between 20-45 years (both male and female) suffering from Cervicogenic Headache (>3 months)
  • Clinically diagnosed with CGH according to ICHD-3 criteria.
  • Patients with pain intensity ≥3 on a Numeric Pain Rating Scale (NPRS)
  • Neck Disability Index (NDI) score ≥ 10% (mild to severe disability)
  • Positive Cervical Flexion Rotation Test. (26)

Exclusion criteria

Exclusion Criteria:

  • Any history of cervical spine trauma, fracture, or recent surgery.
  • Diagnosis of migraine, tension-type headache, or cluster headache
  • Any cervical spine pathology e.g., cervical Disc bulge or Herniation, radiculopathy, cervical myelopathies and arthropathies.
  • Diagnosed inflammatory, infectious, or malignant conditions affecting the cervical spine.
  • Skin conditions or open wounds that contraindicate use of Dynamic cupping e.g., open wounds, skin infections and burns etc. (26)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
41 participants (estimated)

Study arms

  • Experimental
    Dynamic Cupping

    Dynamic Cupping was applied using small sized silicone cups with a gliding technique over massage oil or gel. The target areas included the suboccipital region, upper trapezius and levator scapulae with suction maintained at a mild to moderate level according to patient tolerance. Intervention was delivered 3 sessions per week over 4 weeks, totaling 12 treatment sessions.

    Other: Dynamic Cupping

  • Active comparator
    Facilitated Positional Release technique

    Facilitated Positional Release technique will be applied targeting tender points in the suboccipital region, upper trapezius and levator scapulae. The affected area will be placed in a position of ease to reduce tension, followed by the application of a facilitating force such as compression or rotation for 3-5 seconds to further reduce tissue tension, with the patient positioned supine throughout. Intervention was delivered 3 times per week for 4 weeks, comprising 12 total treatment sessions.

    Other: Facilitated Positional Release technique

Interventions

  • OtherDynamic Cupping

    Dynamic Cupping was applied using small sized silicone cups with a gliding technique over massage oil or gel. The target areas included the suboccipital region, upper trapezius and levator scapulae with suction maintained at a mild to moderate level according to patient tolerance. Intervention was delivered 3 sessions per week over 4 weeks, totaling 12 treatment sessions.

  • OtherFacilitated Positional Release technique

    Facilitated Positional Release technique will be applied targeting tender points in the suboccipital region, upper trapezius and levator scapulae. The affected area will be placed in a position of ease to reduce tension, followed by the application of a facilitating force such as compression or rotation for 3-5 seconds to further reduce tissue tension, with the patient positioned supine throughout. Intervention was delivered 3 times per week for 4 weeks, comprising 12 total treatment sessions.

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale

    The patient is asked to rate their pain by selecting a value on the scale. An 11-point numerical rating scale is used, where "0" indicates no pain and "10" represents the worst pain imaginable at the time of assessment. (27)

    Time frame: Baseline and after 4 weeks

  2. Headache Impact Test-6 (HIT-6)

    The HIT-6 is a six-item questionnaire designed to assess the impact of headaches. Each item is rated on a five-point Likert scale, with responses scored as never (6), rarely (8), sometimes (10), very often (11), and always (13). The scale scores can range between 36 and 78. A score of ≤49 indicates no impact (Grade I), 50-55 represents moderate impact (Grade II), 56-59 indicates significant impact (Grade III), and a score of ≥60 signifies severe impact (Grade IV). The tool evaluates overall quality of life by examining two main domains: pain-related effects, including severity and functional limitation, and psychological and social consequences such as vitality, cognition, role performance, and social functioning. HIT-6 is widely recognized as a reliable and valid measure for assessing headache-related disability. (28) (29)

    Time frame: Baseline and after 4 weeks

  3. Universal Goniometer (UG)

    The range of motion will be measured using a universal goniometer which is a 12-inch transparent plastic model, featuring a protractor scale, two arms, and a fulcrum that has an inter-rater reliability (ICC2, 2 = 0.79 to 0.92) for cervical region. UG requires a high level of examiner proficiency and involves the use of a measurement scale, although the final position does not need to be maintained for immediate reading, as the score can be recorded after completion. The procedure depends on accurate alignment of three anatomical landmarks: the axis, the stationary arm, and the movable arm which requires precise identification of anatomical structures. (30)

    Time frame: Baseline and after 4 weeks

  4. Neck Disability Index (NDI)

    It is a self-reported questionnaire comprising 10 items used to assess the level of disability associated with neck pain. It evaluates various aspects of daily functioning, including pain intensity, personal care, lifting, reading, headaches, concentration, work, driving, sleep, and recreational activities. Each item is scored from 0 to 5, with higher scores reflecting greater disability, resulting in a total possible score of 50. Based on the total score, disability is classified as no disability (0-4), mild disability (5-14), moderate disability (15-24), severe disability (25-34), and complete disability (35 or above). The NDI is a valid and reliable instrument that can be interpreted using either continuous scores or categorical disability levels. (31)

    Time frame: Baseline and after 4 weeks

  5. Pittsburgh Sleep Quality Index (PSQI)

    It is a 19-item self-report questionnaire that assesses sleep quality and sleep-related problems over the previous month. It evaluates areas such as perceived sleep quality, sleep habits, and sleep disturbances. An additional five questions completed by a bed partner may provide clinical information but are not included in scoring. PSQI scoring generates seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component is scored from 0 (no difficulty) to 3 (severe difficulty), producing a global score ranging from 0 to 21. Higher scores indicate poorer sleep quality, and a total score above 5 is generally considered evidence of poor sleep quality. (32)

    Time frame: Baseline and after 4 weeks

07

Study locations

1 site
  • UMT
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: Yes — The results data collected , de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript.

Access criteria: The data can be requested from the corresponding author.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07911254
Lead sponsor
University of Management and Technology Lahore
Responsible party
Sponsor
First posted
Nov 2, 2026
Start date
Oct 27, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 2, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion